ASC: Rapid BP lowering tx no better for intracerebral bleed

May 29, 2013
ASC: rapid BP lowering tx no better for intracerebral bleed
For patients with spontaneous intracerebral hemorrhage and elevated systolic blood pressure, intensive, rapid blood pressure lowering treatment is not associated with a significant reduction in death or severe disability at 90 days compared with guideline-recommended treatment, according to a study published online May 29 in the New England Journal of Medicine to coincide with presentation at the annual European Stroke Conference, held from May 28 to 31 in London.

(HealthDay)—For patients with spontaneous intracerebral hemorrhage and elevated systolic blood pressure, intensive, rapid blood pressure lowering treatment is not associated with a significant reduction in death or severe disability at 90 days compared with guideline-recommended treatment, according to a study published online May 29 in the New England Journal of Medicine to coincide with presentation at the annual European Stroke Conference, held from May 28 to 31 in London.

Craig S. Anderson, M.D., Ph.D., from the George Institute for Global Health at the University of Sydney, and colleagues randomized 2,794 patients with spontaneous intracerebral hemorrhage within the previous six hours, who had elevated systolic blood pressure, to receive intensive blood pressure lowering treatment or guideline-recommended treatment.

The researchers found that the primary outcome of death or major disability at 90 days occurred in 52 percent of those receiving , compared with 55.6 percent of those receiving guideline-recommended treatment (odds ratio with intensive treatment, 0.87; P = 0.06). Significantly lower modified Rankin scores were seen with intensive treatment on ordinal analysis (odds ratio for greater disability, 0.87; P = 0.04). Mortality was 11.9 and 12 percent, respectively, in the intensive treatment and guideline-recommended treatment groups. Nonfatal occurred in 23.3 percent of the intensive treatment group and in 23.6 percent of the guideline-recommended treatment group.

"In patients with intracerebral hemorrhage, intensive lowering of blood pressure did not result in a significant reduction in the rate of the primary outcome of death or severe disability," the authors write.

Several authors disclosed to the pharmaceutical industry.

Explore further: ASH: More intense treatment beneficial in polycythemia vera

More information: Abstract
Full Text
Editorial
More Information

Related Stories

ASH: More intense treatment beneficial in polycythemia vera

December 10, 2012
(HealthDay)—For patients with polycythemia vera, more intense treatment to achieve a hematocrit target of less than 45 percent correlates with a significantly lower rate of cardiovascular death and major thrombosis compared ...

Lower blood pressure targets safe in reducing risk of recurrent stroke

February 11, 2013
Stroke patients who lowered their systolic blood pressure below 130 mm Hg were significantly less likely to have a recurrent stroke caused by a brain bleed compared with those who didn't lower their pressure that far, according ...

ATS: Early prone positioning reduces mortality in ARDS

May 21, 2013
(HealthDay)—For patients with acute respiratory distress syndrome (ARDS), prolonged prone positioning during mechanical ventilation is associated with significantly reduced mortality at 28 and 90 days, according to a study ...

Study identifies superior hypertension treatment, efficacy between sexes

May 21, 2013
(Medical Xpress)—In a recent subgroup analysis of the largest blood pressure treatment trial in history, University of Alabama at Birmingham (UAB) researchers found that women and men react the same to non-diuretic-based ...

Home blood pressure monitoring may not benefit patients with stroke and hypertension

November 5, 2012
Home blood pressure monitoring may help patients with hypertension and stroke but did not improve blood pressure control for patients who had normal blood pressure at the start or those with disabilities, according to a randomized ...

Recommended for you

Anti-malaria drug shows promise as Zika virus treatment

November 17, 2017
A new collaborative study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) and UC San Diego School of Medicine has found that a medication used to prevent and treat malaria may also be effective ...

Decrease in sunshine, increase in Rickets

November 17, 2017
A University of Toronto student and professor have teamed up to discover that Britain's increasing cloudiness during the summer could be an important reason for the mysterious increase in Rickets among British children over ...

Scientists identify biomarkers that indicate likelihood of survival in infected patients

November 17, 2017
Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.

Research team unlocks secrets of Ebola

November 16, 2017
In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published today (Nov. 16, 2017) in Cell Host and Microbe, a scientific team led by the University of Wisconsin-Madison has ...

Study raises possibility of naturally acquired immunity against Zika virus

November 16, 2017
Birth defects in babies born infected with Zika virus remain a major health concern. Now, scientists suggest the possibility that some women in high-risk Zika regions may already be protected and not know it.

A structural clue to attacking malaria's 'Achilles heel'

November 16, 2017
Researchers from The Scripps Research Institute (TSRI) and PATH's Malaria Vaccine Initiative (MVI) have shed light on how the human immune system recognizes the malaria parasite though investigation of antibodies generated ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.